PFIZER INC Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit
PFIZER INC (PFE) had Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit of -$100.00 million as of 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit · last filed 2017-02-23
- 2016-12-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit -$100.00M.
- 2015-12-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit -$200.00M.
- 2013-12-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit -$100.00M; Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit as first filed $300.00M.
| Period end | Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit | Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit as first filed |
|---|---|---|
| 2016-12-31 | -$100.00M 10-K · filed 2017-02-23 | |
| 2015-12-31 | -$200.00M 10-K · filed 2016-02-29 | |
| 2013-12-31 | -$100.00M 10-K · filed 2015-02-27 | $300.00M 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |